An H-1-Parvovirus bindender Antikörper

European patent · EP2332986 · In force

Register entry

Publication number
EP2332986
Application number
EP09015373
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 11, 2009
Published
Jun 15, 2011
Granted
Oct 9, 2013
Protection ends at the latest
Dec 10, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/08 (2006.01)
G01N 33/569 (2006.01)
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 26, 2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 26.06.2026

  2. Jun 26, 2025

    Next annual fee due on

    Next annual fee due on
    31.12.2024 → 31.12.2025

    Published in Swissreg on 26.06.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Nov 1, 2013

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 01.11.2013

  6. Oct 9, 2013

    Granted

    Published in Swissreg on 09.10.2013

Parties

Holder

Deutsches Krebsforschungszentrum

Im Neuenheimer Feld 280, 69120 Heidelberg, DE

Agent

Ing. Marco Zardi c/o M. ZARDI & Co. S.A.

via Pioda 6, 6900 Lugano

Inventor

Leuchs, Barbara

69123 Heidelberg, DE

Kürschner, Kathrin

69124 Heidelberg, DE

Kern, Andrea

74930 Ittlingen, DE

Müller, Marcus

74906 Bad Rappenau, DE

Münsterman, Silvia

69151 Neckargemünd, DE

Rommelaere, Jean

69118 Heidelberg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.